GL GoodLife 001 Blood Glucose Monitoring System - Taiwan Registration 298d5b644d0bd36966f1486422b6109e
Access comprehensive regulatory information for GL GoodLife 001 Blood Glucose Monitoring System in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 298d5b644d0bd36966f1486422b6109e and manufactured by HMD BIOMEDICAL INC.. The authorized representative in Taiwan is HMD BIOMEDICAL INC..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
298d5b644d0bd36966f1486422b6109e
Ministry of Health Medical Device Manufacturing No. 006264
Product Details
This product is made using electrochemical biosensing technology and can only be used with Good Life Blood Glucose Test Tablets, providing diabetic patients with home detection of microvascular whole blood glucose values. And under the operation of professional nursing staff in the hospital, the blood glucose values of adult microvascular, venous blood and neonatal whole blood can be detected.
A Clinical chemistry and clinical toxicology
A1345 Glucose Test System
Produced in Taiwan, China
Dates and Status
Nov 23, 2018
Jun 20, 2026